T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals

Journal of Immunology

Volumn 172, Issue 6, 2004, Pages 3883-3892

  Veldman, Christian M ^a   Gebhard, Kerstin L ^a   Uter, Wolfgang ^a   Wassmuth, Ralf ^b   Grötzinger, Joachim ^c   Schultz, Erwin ^a   Hertl, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; AUTOANTIBODY; CELL ADHESION MOLECULE; DESMOGLEIN 3; HLA ANTIGEN; HLA ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOLECULAR RECOGNITION; PEMPHIGUS VULGARIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN MOTIF; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 1542619242     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.6.3883     Document Type: Article

References (47)

1. Amagai, M., V. Klaus-Kovtun, and J. R. Stanley. I991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869.
2. Stanley, J. R. 1989. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J. Clin. Invest. 83:1443.
3. Amagai, M., S. Karpati, R. Prussick, V. Klaus-Kovtun, and J. R. Stanley. 1992. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J. Clin. Invest. 90:919.
4. Ding, X., V. Aoki, J. M. Mascaro, Jr., A. Lopez-Swiderski, L. A. Diaz, and J. A. Fairley. 1997. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J. Invest. Dermatol. 109:592.
5. Anhalt, G. J., and L. A. Diaz. 1989. In vivo studies of antibody dependent acantholysis. Immunol. Ser. 46:291.
6. Koch, P. J., M. G. Mahoney, H. Ishikawa, L. Pulkkinen, J. Uitto, L. Shultz, G. F. Murphy, D. Whitaker-Menezes, and J. R. Stanley. 1997. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J. Cell Biol. 137:1091.
7. Nguyen, V. T., A. Ndoye, and S. A. Grando. 2000. Pemphigus vulgaris antibody identifies pemphaxin: a novel keratinocyte annexin-like molecule binding acetylcholine. J. Biol. Chem. 275:29466.
8. Nguyen, V. T., A. Ndoye, and S. A. Grando. 2000. Novel human α9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am. J. Pathol. 157:1377.
9. Kljuic, A., H. Bazzi, J. P. Sundberg, A. Martinez-Mir, R. O'Shaughnessy, M. G. Mahoney, M. Levy, X. Montagutelli, W. Ahmad, V. M. Aita, et al. 2003. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 113:249.
10. Huilgol, S. C., and M. M. Black. 1995. Management of the immunobullous disorders. II. Pemphigus. Clin. Exp. Dermatol. 20:283.
11. Mahoney, M. G., Z. Wang, K. Rothenberger, P. J. Koch, M. Amagai, and J. R. Stanley. 1999. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J. Clin. Invest. 103:461.
12. Ishii, K., M. Amagai, R. P. Hall, T. Hashimoto, A. Takayanagi, S. Gamou, N. Shimizu, and T. Nishikawa. 1997. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol. 159:2010.
13. Jones, C. C., R. G. Hamilton, and R. E. Jordon. 1988. Subclass distribution of human IgG autoantibodies in pemphigus. J. Clin. Immunol. 8:43.
14. Bhol K., K. Natarajan, N. Nagarwalla, A. Mohimen, V. Aoki, and A. R. Ahmed. 1995. Correlation of peptide specifity and IgG subclass with pathogenetic and nonpathogenetic autoantibodies in pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 92:5243.
15. Amagai, M., T. Hashimoto, K. J. Green, N. Shimizu, and T. Nishikawa. 1995. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Invest. Dermatol. 104:895.
16. Ahmed, A. R., E. J. Yunis, K. Khatri, R. Wagner, G. Notani, Z. Awdeh, and C. A. Alper. 1990. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 87:7658.
17. Ahmed, A. R., R. Wagner, K. Khatri, G. Notani, Z. Awdeh, C. A. Alper, and E. J. Yunis. 1991. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 88:5056.
18. Sinha, A. A., C. Brautbar, F. Szafer, A. Friedmann, E. Tzfoni, J. A. Todd, L. Steinman, and H. O. McDevitt. 1988. A newly characterized HLA DQ β allele associated with pemphigus vulgaris. Science 239:1026.
19. Wucherpfennig, K. W., B. Yu, K. Bhol, D. S. Monos, E. Argyris, R. W. Karr, A. R. Ahmed, and J. L. Strominger. 1995. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 92:11935.
20. Lin, M. S., S. J. Swartz, A. Lopez, X. Ding, M. A. Femandez-Vina, P. Stastny, J. A. Fairley, and L. A. Diaz. 1997. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J. Clin. Invest. 99:31.
21. Hertl, M., M. Amagai, H. Sundaram, J. Stanley, K. Ishii, and S. I. Katz. 1998. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J. Invest. Dermatol. 110:62.
22. Veldman, C., A. Stauber, R. Wassmuth, W. Uter, G. Schuler, and M. Hertl. 2003. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J. Immunol. 170:635.
23. Nishifuji, K., M. Amagai, M. Kuwana, T. Iwasaki, and T. Nishikawa. 2000. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J. Invest. Dermatol. 114:88.
24. Spaeth, S., R. Riechers, L. Borradori, D. Zillikens, L. Budinger, and M. Hertl. 2001. IgG, IgA, and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. Br. J. Dermatol. 144:1183.
25. Manz, R., M. Assenmacher, E. Pfluger, S. Miltenyi, and A. Radbruch. 1995. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc. Natl. Acad. Sci. USA 92:1921.
26. Budinger, L., L. Borradori, C. Yee, R. Eming, S. Ferencik, H. Grosse-Wilde, H. F. Merk, K. Yancey, and M. Hertl. 1998. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J. Clin. Invest. 102:2082.
27. Vriend, G. 1990. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8:52.
28. van Gunsteren, W. F., S. R. Billeter, A. A. Eising, P. H. Hühnenberger, P. Krüger, A. E. Mark, W. R. P. Scott, and I. G. Tironi. 1996. Biomolecular Simulation: The GROMOS 96 Manual and User Guide. vdf Hochschul-Verlag AG, Zuerich.
29. Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281.
30. Riechers, R., J. Grotzinger, and M. Hertl. 1999. HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy. Autoimmunity 30:183.
31. Sekiguchi, M., Y. Futei, Y. Fujii, T. Iwasaki, T. Nishikawa, and M. Amagai. 2001. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J. Immunol. 167:5439.
32. Tsunoda, K., T. Ota, M. Aoki, T. Yamada, T. Nagai, T. Nakagawa, S. Koyasu, T. Nishikawa, and M. Amagai. 2003. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J. Immunol. 170:2170.
33. Wucherpfennig, K. W., and J. L. Strominger. 1995. Selective binding of self peptides of disease-associated major histocompatibility complex (MHC) molecues: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597.
34. Hammer, J., F. Gallazzi, E. Bono, R. W. Karr, J. Guenot, P. Valsasnini, Z. A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847.
35. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.
36. Li, N., V. Aoki, G. Hans-Filho, E. A. Rivitti, and L. A. Diaz. 2003. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J. Exp. Med. 197:1501.
37. Kawana, S., T. Hashimoto, T. Nishikawa, and S. Nishiyama. 1994. Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris. Arch. Dermatol. 130:1534.
38. Harman, K. E., M. J. Gratian, P. J. Shirlaw, B. S. Bhogal, S. J. Challacombe, and M. M. Black. 2002. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein I and 3 autoantibody levels in pemphigus vulgaris. Br. J. Dermatol. 146:684.
39. Schafer, S., P. J. Koch, and W. W. Franke. 1994. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins. Exp. Cell Res. 211:391.
40. Pu, Z., J. A. Carrero, and E. R. Unanue. 2002. Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc. Natl. Acad. Sci. USA 99:8844.
41. Pette, M., K. Fujita, D. Wilkinson, D. M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J. T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autore-activity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87:7968.
42. + T cells in vitro. J. Virol. 70:7540.
43. Hertl, M., R. W. Karr, M. Amagai, and S. I. Katz. 1998. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals. J. Invest. Dermatol. 110:388.
44. Kwok, W., W. G. T. Nepom, and F. C. Raymond. 1995. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155:2468.
45. Nepom, B. S., G. T. Nepom, M. Coleman, and W. W. Kwok. 1996. Critical contribution of β-chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. USA 93:7202.
46. Hacker, M. K., J. A. Fairley, and M. Lin. 2003. T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris. J. Invest. Dermatol. 121:1365.
47. Moesta, A. K., M. S. Lin, L. A. Diaz, and A. A. Sinha. 2002. T cell receptor β-chain gene usage in endemic pemphigus foliaceus (fogo selvagem). J. Invest. Dermatol. 119:377.